292 related articles for article (PubMed ID: 27920474)
21. Anti-hepatitis B virus activities of α-DDB-FNC, a novel nucleoside-biphenyldicarboxylate compound in cells and ducks, and its anti-immunological liver injury effect in mice.
Yang Q; Zhao X; Zang L; Fang X; Zhao J; Yang X; Wang Q; Zheng L; Chang J
Antiviral Res; 2012 Dec; 96(3):333-9. PubMed ID: 23098744
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells.
Liu Z; Dai X; Wang T; Zhang C; Zhang W; Zhang W; Zhang Q; Wu K; Liu F; Liu Y; Wu J
Cancer Lett; 2017 Aug; 400():149-160. PubMed ID: 28455240
[TBL] [Abstract][Full Text] [Related]
23. Occult hepatitis B virus infection with positive hepatitis B e antigen.
Han Z; Liu Y; Pan J; Bi Y; Liu J; Zhou YH
Clin Chim Acta; 2015 Jan; 438():266-8. PubMed ID: 25218700
[TBL] [Abstract][Full Text] [Related]
24. NIRF, a Novel Ubiquitin Ligase, Inhibits Hepatitis B Virus Replication Through Effect on HBV Core Protein and H3 Histones.
Qian G; Hu B; Zhou D; Xuan Y; Bai L; Duan C
DNA Cell Biol; 2015 May; 34(5):327-32. PubMed ID: 25664994
[TBL] [Abstract][Full Text] [Related]
25. Defective DNA damage response and repair in liver cells expressing hepatitis B virus surface antigen.
Chung YL
FASEB J; 2013 Jun; 27(6):2316-27. PubMed ID: 23444429
[TBL] [Abstract][Full Text] [Related]
26. Defined host factors support HBV infection in non-hepatic 293T cells.
Yang X; Cai W; Sun X; Bi Y; Zeng C; Zhao X; Zhou Q; Xu T; Xie Q; Sun P; Zhou X
J Cell Mol Med; 2020 Feb; 24(4):2507-2518. PubMed ID: 31930674
[TBL] [Abstract][Full Text] [Related]
27. miR146a impairs the IFN-induced anti-HBV immune response by downregulating STAT1 in hepatocytes.
Hou ZH; Han QJ; Zhang C; Tian ZG; Zhang J
Liver Int; 2014 Jan; 34(1):58-68. PubMed ID: 23890093
[TBL] [Abstract][Full Text] [Related]
28. Alpha-enolase regulates hepatitis B virus replication through suppression of the interferon signalling pathway.
Xiang-Chun D; Xiao-Qing Y; Ting-Ting Y; Zhen-Hui L; Xiao-Yan L; Xia L; Yan-Chao H; Yi-Xuan Y; Li-Na M
J Viral Hepat; 2018 Mar; 25(3):289-295. PubMed ID: 29080231
[TBL] [Abstract][Full Text] [Related]
29. In vitro infection of human hepatoma cells (HepG2) with hepatitis B virus (HBV): spontaneous selection of a stable HBV surface antigen-producing HepG2 cell line containing integrated HBV DNA sequences.
Mabit H; Dubanchet S; Capel F; Dauguet C; Petit MA
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2681-9. PubMed ID: 7931154
[TBL] [Abstract][Full Text] [Related]
30. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels.
Pollicino T; Amaddeo G; Restuccia A; Raffa G; Alibrandi A; Cutroneo G; Favaloro A; Maimone S; Squadrito G; Raimondo G
Hepatology; 2012 Aug; 56(2):434-43. PubMed ID: 22271491
[TBL] [Abstract][Full Text] [Related]
31. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
[TBL] [Abstract][Full Text] [Related]
32. Doubly Spliced RNA of Hepatitis B Virus Suppresses Viral Transcription via TATA-Binding Protein and Induces Stress Granule Assembly.
Tsai KN; Chong CL; Chou YC; Huang CC; Wang YL; Wang SW; Chen ML; Chen CH; Chang C
J Virol; 2015 Nov; 89(22):11406-19. PubMed ID: 26339052
[TBL] [Abstract][Full Text] [Related]
33. miR-29a promotes hepatitis B virus replication and expression by targeting SMARCE1 in hepatoma carcinoma.
Wu HJ; Zhuo Y; Zhou YC; Wang XW; Wang YP; Si CY; Wang XH
World J Gastroenterol; 2017 Jul; 23(25):4569-4578. PubMed ID: 28740345
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth.
Xiangji L; Feng X; Qingbao C; Weifeng T; Xiaoqing J; Baihe Z; Feng S; Hongyang W; Mengchao W
J Viral Hepat; 2011 Sep; 18(9):653-60. PubMed ID: 20642484
[TBL] [Abstract][Full Text] [Related]
35. Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen.
Iser DM; Warner N; Revill PA; Solomon A; Wightman F; Saleh S; Crane M; Cameron PU; Bowden S; Nguyen T; Pereira CF; Desmond PV; Locarnini SA; Lewin SR
J Virol; 2010 Jun; 84(12):5860-7. PubMed ID: 20357083
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1.
Lu ZP; Xiao ZL; Yang Z; Li J; Feng GX; Chen FQ; Li YH; Feng JY; Gao YE; Ye LH; Zhang XD
Acta Pharmacol Sin; 2015 Oct; 36(10):1228-36. PubMed ID: 26073327
[TBL] [Abstract][Full Text] [Related]
37. Human hepatitis B virus surface and e antigens inhibit major vault protein signaling in interferon induction pathways.
Liu S; Peng N; Xie J; Hao Q; Zhang M; Zhang Y; Xia Z; Xu G; Zhao F; Wang Q; Han T; Zhu Y
J Hepatol; 2015 May; 62(5):1015-23. PubMed ID: 25481566
[TBL] [Abstract][Full Text] [Related]
38. The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers.
Treichel U; Meyer zum Büschenfelde KH; Stockert RJ; Poralla T; Gerken G
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3021-9. PubMed ID: 7964611
[TBL] [Abstract][Full Text] [Related]
39. HSPB1 is an intracellular antiviral factor against hepatitis B virus.
Tong SW; Yang YX; Hu HD; An X; Ye F; Ren H; Li SL; Zhang DZ
J Cell Biochem; 2013 Jan; 114(1):162-73. PubMed ID: 22887120
[TBL] [Abstract][Full Text] [Related]
40. Efficient delivery of HBV NLS siRNAs into HepG2.2.15 cells for HBV inhibition through novel recombinant preS1‑tP proteins.
Zeng Y; Li Z; Shang J; Kang Y
Int J Mol Med; 2018 Aug; 42(2):1181-1189. PubMed ID: 29786106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]